[
    [
        {
            "time": "",
            "original_text": "[强烈推荐评级]健帆生物(300529)：中报业绩预增30%-50%略超市场预期 成长不断加快",
            "features": {
                "keywords": [
                    "健帆生物",
                    "中报业绩",
                    "预增",
                    "30%-50%",
                    "市场预期",
                    "成长加快"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强烈推荐评级]健帆生物(300529)：中报业绩预增30%-50%略超市场预期 成长不断加快",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]